Hudson Capital Management’s Pfizer PFE Stock Holding History

Hudson Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,348	Closed	-$223K	–	70
2022 Q4	$223K	Buy	+4,348	New	+$208K	0.09%	61
2022 Q3	–	Sell	-4,348	Closed	-$228K	–	65
2022 Q2	$228K	Hold	4,348	–	–	0.11%	62
2022 Q1	$225K	Hold	4,348	–	–	0.09%	62
2021 Q4	$257K	Buy	+4,348	New	+$215K	0.09%	64
2020 Q4	–	Sell	-7,385	Closed	-$257K	–	66
2020 Q3	$257K	Sell	7,385 -796	-10%	-$27.9K	0.13%	56
2020 Q2	$254K	Hold	8,181	–	–	0.14%	64
2020 Q1	$253K	Sell	8,181 -1,312	-14%	-$44.7K	0.17%	57
2019 Q4	$353K	Sell	9,493 -422	-4%	-$15K	0.18%	54
2019 Q3	$338K	Sell	9,915 -4,434	-31%	-$161K	0.19%	56
2019 Q2	$590K	Sell	14,349 -5,142	-26%	-$204K	0.33%	53
2019 Q1	$785K	Buy	19,491 +65	+0.3%	+$2.6K	0.48%	49
2018 Q4	$805K	Buy	19,426 +477	+3%	+$19.8K	0.59%	45
2018 Q3	$792K	Sell	18,949 -924	-5%	-$35.6K	0.6%	45
2018 Q2	$684K	Sell	19,873 -3,255	-14%	-$111K	0.48%	54
2018 Q1	$779K	Sell	23,128 -644	-3%	-$22.1K	0.57%	52
2017 Q4	$817K	Buy	+23,772	New	+$811K	0.6%	51

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hudson Capital Management's PFE Position: Q1 2023 in Review

Hudson Capital Management sold out of Pfizer (PFE) in Q1 2023, closing a stake of 4,348 shares — an estimated $223K sold.

Hudson Capital Management first reported a position in PFE in Q4 2017 and held it in 16 quarters. The position peaked at $817K in Q4 2017. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

Hudson Capital Management reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
Hudson Capital Management sold 4,348 Pfizer shares in Q1 2023, an estimated $223K.
Hudson Capital Management first reported a position in Pfizer in Q4 2017 and held it in 16 quarters.
Hudson Capital Management's Pfizer position peaked at $817K in Q4 2017.
3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Hudson Capital Management's 13F filing for Q1 2023, filed 18 Apr 2023.